This culminated in the presence of anti-carcinoembryonic antigen (CEA) antibodies (22) and anti-beta-galactosidase antibodies and CTLs (23) after mRNA administration, which supported the idea of delivering mRNA encoding tumor antigens. Here, CEACAM5 is linked to neoplasm.